Profil News

Our expert

Dr. Lars Bochmann

Director Marketing & Business Development

October 1, 2019

Finally breakthrough in the immunological approach to type 1 diabetes

Type 1 diabetes is a T-cell mediated autoimmune disease. For more than 40 years, researchers have tried to intervene in the autoimmune process to halt or perhaps even reverse the slow destruction of

September 17, 2019

Current developments in approaches to bridging studies

Waiving Bridging studies under certain circumstances for biosimilar applications? A bridging study is a study performed in a new region to provide pharmacodynamic or clinical data on efficacy,

September 3, 2019

iPDM Goes Europe: tangible impact on diabetes patients and care

Treatment inertia calls for an integrated personalized diabetes management: iPDM Diabetes represents a huge and multidimensional challenge for European societes. It not only leads to premature ageing

August 21, 2019

New PID-algorithm for automated glucose clamps

Introduction The euglycemic, hyperinsulinemic glucose clamp is the gold standard for the determination of pharmacokinetic and pharmacodynamic (PK/PD) effects of new anti-diabetic drugs, in particular

July 23, 2019

"Profil World" - The clinical diabetes research newsletter - July 2019

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

July 16, 2019

Dual-hormone artificial pancreas systems

Dual-hormone artificial pancreas systems use insulin and glucagon to control glucose in patients with diabetes - a dream is about to come true Insulin-only closed-loop AP systems hold promise for

July 2, 2019

Dr. Tim Heise about Profil's 2018 Science Report

Dear all, It is my great honour and pride to present the Profil Science Report 2018. Altogether, Profil’s scientific experts published 29 scientific publications (cumulated impact factor of > 150)

June 18, 2019

Is there a ‘true’ insulin time action profile?

The impact of different study populations in glucose clamp studies Over the last decade, the euglycemic clamp technique has evolved to the reference method for assessing time action profiles of

June 4, 2019

Applications of iontophoresis in studies investigating microvasculature

People suffering from Diabetes Mellitus can develop both macrovascular and microvascular complications. Retinopathy, nephropathy and neuropathy are the main microvascular complications occurring in

Profil Germany News

See what’s new at Profil